BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10435083)

  • 21. [The HSV-TK/GCV gene therapy in five cases of recurrent glioblastoma multiforme].
    Adachi N; Könü DL; Frei K; Yonekawa Y
    No Shinkei Geka; 2000 Oct; 28(10):865-71. PubMed ID: 11070906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging-guided convection-enhanced delivery and gene therapy of glioblastoma.
    Voges J; Reszka R; Gossmann A; Dittmar C; Richter R; Garlip G; Kracht L; Coenen HH; Sturm V; Wienhard K; Heiss WD; Jacobs AH
    Ann Neurol; 2003 Oct; 54(4):479-87. PubMed ID: 14520660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [French clinical trials of gene therapy with "suicide gene"].
    Jeanteur P
    Bull Cancer; 1999 Feb; 86(2):137-8. PubMed ID: 10094522
    [No Abstract]   [Full Text] [Related]  

  • 24. Cure following gene therapy for recurrent glioblastoma multiforme?
    Karabatsou K; Bernstein M
    Acta Neurochir (Wien); 2008 Jun; 150(6):611-2. PubMed ID: 18511998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene therapy vectors containing CArG elements from the Egr1 gene are activated by neutron irradiation, cisplatin and doxorubicin.
    Greco O; Powell TM; Marples B; Joiner MC; Scott SD
    Cancer Gene Ther; 2005 Jul; 12(7):655-62. PubMed ID: 15818381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced pancreatic tumor regression by a combination of adenovirus and retrovirus-mediated delivery of the herpes simplex virus thymidine kinase gene.
    Carrió M; Romagosa A; Mercadé E; Mazo A; Nadal M; Gómez-Foix AM; Fillat C
    Gene Ther; 1999 Apr; 6(4):547-53. PubMed ID: 10476214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model.
    Tyynelä K; Sandmair AM; Turunen M; Vanninen R; Vainio P; Kauppinen R; Johansson R; Vapalahti M; Ylä-Herttuala S
    Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms.
    Kruse CA; Lamb C; Hogan S; Smiley WR; Kleinschmidt-Demasters BK; Burrows FJ
    Cancer Gene Ther; 2000 Jan; 7(1):118-27. PubMed ID: 10678364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Using the thymidine kinase gene in therapy of solid tumors].
    Wicke I; Gansbacher B
    Internist (Berl); 1996 Apr; 37(4):369-73. PubMed ID: 8655273
    [No Abstract]   [Full Text] [Related]  

  • 31. Suicide gene therapy of human breast cancer in SCID mice model by the regulation of Tet-On.
    Hu WX; Zeng ZJ; Luo SQ; Chen Q
    Chin Med J (Engl); 2004 Mar; 117(3):434-9. PubMed ID: 15043787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer gene therapy by thyroid hormone-mediated expression of toxin genes.
    Martín V; Cortés ML; de Felipe P; Farsetti A; Calcaterra NB; Izquierdo M
    Cancer Res; 2000 Jun; 60(12):3218-24. PubMed ID: 10866314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Highly efficient suicide gene expression in hepatocellular carcinoma cells by epstein-barr virus-based plasmid vectors combined with polyamidoamine dendrimer.
    Harada Y; Iwai M; Tanaka S; Okanoue T; Kashima K; Maruyama-Tabata H; Hirai H; Satoh E; Imanishi J; Mazda O
    Cancer Gene Ther; 2000 Jan; 7(1):27-36. PubMed ID: 10678353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene therapy for glioblastoma.
    Aghi M; Chiocca EA
    Neurosurg Focus; 2006 Apr; 20(4):E18. PubMed ID: 16709023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combine cancer gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and Herpes simplex thymidine kinase suicide gene.
    Pastorakova A; Hlubinova K; Jakubikova J; Altaner C
    Neoplasma; 2006; 53(5):353-62. PubMed ID: 17013529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of cellular- and prodrug-associated factors in the bystander effect induced by the Varicella zoster and Herpes simplex viral thymidine kinases in suicide gene therapy.
    Grignet-Debrus C; Cool V; Baudson N; Velu T; Calberg-Bacq CM
    Cancer Gene Ther; 2000 Nov; 7(11):1456-68. PubMed ID: 11129288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination suicide/cytokine gene therapy as adjuvants to a defective herpes simplex virus-based cancer vaccine.
    Toda M; Martuza RL; Rabkin SD
    Gene Ther; 2001 Feb; 8(4):332-9. PubMed ID: 11313808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
    Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
    Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
    Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-Azacytidine prevents transgene methylation in vivo.
    Di Ianni M; Terenzi A; Perruccio K; Ciurnelli R; Lucheroni F; Benedetti R; Martelli MF; Tabilio A
    Gene Ther; 1999 Apr; 6(4):703-7. PubMed ID: 10476232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.